home / stock / fbio / fbio articles

FBIO Articles, Fortress Biotech Inc. - From 07/15/24

Stock Information
Company Name: Fortress Biotech Inc.
Stock Symbol: FBIO
Market: NASDAQ
Website: fortressbiotech.com
Menu
FBIO FBIO Quote FBIO Short FBIO News FBIO Articles FBIO Message Board
Get FBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research | Benzinga

Collaboration explores the potential synergistic effects of Checkpoint's anti-PD-L1, cosibelimab, in combination with the autologous T cell ...
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed mostly lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their co...

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors | Benzinga

SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical"), a commercial-stage pharmaceu...

Insiders Buying Fortress Biotech And 2 Other Stocks | Benzinga

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confide...
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday | Benzinga

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street ex...

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | Benzinga

MIAMI, July 05, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO, FBIOP)) ("Fortress"), an innovative biopharmaceutical company focu...

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Benzinga

WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceut...
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference | Benzinga

MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company...

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Benzinga

WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceut...

Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? | Benzinga

Penny stock Mustang Bio Inc (NASDAQ:MBIO) shares are trading higher on a strong session volume of 90 million versus an average volume of 3.17 milli...
Previous 10 Next 10